Cite
Gordon O, Brosnan MK, Yoon S, et al. Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children. JCI Insight. 2021;doi: 10.1172/jci.insight.151518.
Gordon, O., Brosnan, M. K., Yoon, S., Jung, D., Littlefield, K., Ganesan, A., Caputo, C. A., Li, M., Morgenlander, W. R., Henson, S. N., Ordonez, A. A., De Jesus, P., Tucker, E. W., Peart Akindele, N., Ma, Z., Wilson, J., Ruiz-Bedoya, C. A., Younger, M. E. M., Bloch, E. M., Shoham, S., Sullivan, D., Tobian, A. A., Cooke, K. R., Larman, B., Gobburu, J. V., Casadevall, A., Pekosz, A., Lederman, H. M., Klein, S. L., & Jain, S. K. (2021). Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children. JCI insight, . https://doi.org/10.1172/jci.insight.151518
Gordon, Oren, et al. "Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children." JCI insight vol. (2021). doi: https://doi.org/10.1172/jci.insight.151518
Gordon O, Brosnan MK, Yoon S, Jung D, Littlefield K, Ganesan A, Caputo CA, Li M, Morgenlander WR, Henson SN, Ordonez AA, De Jesus P, Tucker EW, Peart Akindele N, Ma Z, Wilson J, Ruiz-Bedoya CA, Younger MEM, Bloch EM, Shoham S, Sullivan D, Tobian AA, Cooke KR, Larman B, Gobburu JV, Casadevall A, Pekosz A, Lederman HM, Klein SL, Jain SK. Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children. JCI Insight. 2021 Dec 02; doi: 10.1172/jci.insight.151518. Epub 2021 Dec 02. PMID: 34855624.
Copy
Download .nbib